What sponsors need from their clinical research partners can shift year to year, which is why ISR asks our respondents about which attributes they believe to be rising in importance when choosing between preferred providers. Below, we share the top three attributes gaining in importance across all clinical phases.

These data were aggregated from our latest CRO Benchmarking Suite. Whether you’re looking for Phase I, Phase II/III, or Phase IV clinical research partners, ISR has the usage, preference, and leadership data you need to outsource with confidence.

Originally published in Life Science Leader.

View File